Advocates gathered at the Alabama Statehouse Tuesday urging lawmakers to reconsider their long-held reluctance to expand ...
27m
SB161 would require that non-opioid pain treatments that have FDA approval be included on this preferred drug list with coverage terms that are no more restrictive than those given to opioid pain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback